graph EGM comparisons
docetaxel plus ADTtitleandrogen deprivation therapy (ADT)titleNCI E3805 (Scott), 2017 NCT00309985 metastatic, hormone-sensitive prostate cancer 397/393STAMPEDE docetaxel, 2016 NCT00268476 metastatic, hormone-sensitive prostate cancer -9/-9CHAARTED, 0 NCT00268476 metastatic, hormone-sensitive prostate cancer -9/-9GETUG-AFU 15, 2013 NCT00104715 metastatic, hormone-sensitive prostate cancer -9/-9

Pathology:  metastatic, hormone-sensitive prostate cancer; 

metastatic, hormone-sensitive prostate cancer
NCI E3805 (Scott), 2017STAMPEDE docetaxel, 2016CHAARTED, 0GETUG-AFU 15, 2013
docetaxel plus ADT4T1T1T1T1
androgen deprivation therapy (ADT)0T0T0T0T0